Advertisement

CEN Case Reports

, Volume 7, Issue 2, pp 195–197 | Cite as

Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome

  • T. Harish Varma
  • Ashish Sharma
  • S. Santhiya
  • Lesa Dawman
  • Karalanglin Tiewsoh
Case Report
  • 62 Downloads

Abstract

Furosemide is one of the most common drug used to treat anasarca in childhood nephrotic syndrome. It has minimal side effects on short-term usage, but prolonged use can result in polyuria, hypokalemia and metabolic alkalosis. This pseudo-bartter complication can be treated by discontinuation of the drug with adequate potassium replacement. We report a child who was given furosemide for 20 days elsewhere to treat the edema due to nephrotic syndrome and then presented to us with bartter-like syndrome. Furosemide was discontinued and potassium replacement was initiated. However, the child continued to have polyuria leading to repeated episodes of hypotensive shock. In view of severe symptoms, she was given a short course of oral indomethacin for 6 days, to which she responded. This case highlights the fact that indomethacin can provide symptomatic improvement in furosemide induced pseudo-bartter.

Keywords

Furosemide Pseudo bartter syndrome Potassium Metabolic alkalosis Indomethacin 

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Research involving human participants and/or animals

Due permission from the Departmental Review Board was taken.

Informed consent

Taken.

References

  1. 1.
    Keller E, Hoppe-Seyler G, Schollmeyer P. Disposition and diuretic effect of furosemide in the nephritic syndrome. Clin Pharmacol Ther. 1982 32(4):442–9.CrossRefGoogle Scholar
  2. 2.
    Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, Branch RA. Plasma binding and disposition of furosemide in the nephritic syndrome and in uremia. Clin Pharmacol Ther 1978; 24(2):199–207.CrossRefGoogle Scholar
  3. 3.
    Colussi G, Rombolà G, Airaghi C, De Ferrari ME, Minetti L. Pseudo-Bartter’s syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter’s syndrome. Nephrol Dial Transpl. 1992;7:896–901.CrossRefGoogle Scholar
  4. 4.
    Numabe A, Ogata A, Abe M, Takahashi M, Kono K, Arakawa M, Ishimitsu T, Ieiri T, Matsuoka H, Yagi S. A case of pseudo-Bartter’s syndrome induced by long-term ingestion of furosemide delivered orally through health tea. Nihon Jinzo Gakkai Shi. 2003;45:457–63.PubMedGoogle Scholar
  5. 5.
    Vasudevan A, Mantan M, Bagga A. Management of edema in nephrotic syndrome. Indian Pediatr. 2004;41(8):787 – 95.PubMedGoogle Scholar
  6. 6.
    Schepkens H, Hoeben H, Vanholder R, Lameire N. Mimicry of surreptitious diuretic ingestion and the ability to make a genetic diagnosis. Clin Nephrol. 2001;55:233–7.PubMedGoogle Scholar
  7. 7.
    Ruisz, et al. Furosemide-induced severe hypokalemia with rhabdomyolysis without cardiac arrest. BMC Women’s Health. 2013;13:30.CrossRefGoogle Scholar
  8. 8.
    Unwin RJ, Capasso G. Bartter’s and Gitelman’s syndromes: their relationship to the actions of loop and thiazide diuretics. Curr Opin Pharmacol. 2006;6:208–13.CrossRefGoogle Scholar
  9. 9.
    Kammerl MC, Nüsing RM, Richthammer W, Krämer BK, Kurtz A. Inhibition of COX-2 counteracts the effects of diuretics in rats. Kidney Int. 2001;60(5):1684–91.CrossRefGoogle Scholar
  10. 10.
    Sasaki H, Kawasaki T, Yamamoto T, Ninomiya H, et al. Pseudo-Bartter’s syndrome induced by surreptitious ingestion of furosemide to lose weight: a case report and possible pathophysiology. Nihon Naibunpi Gakkai Zasshi. 1986;62(8):867–81.PubMedGoogle Scholar
  11. 11.
    Sasaki H, Okumura M, Kawasaki T, Kangawa K, Matsuo H. Indomethacin and atrial natriuretic peptide in pseudo-Bartter’s syndrome. N Engl J Med. 1987;316(3):167PubMedGoogle Scholar
  12. 12.
    Seyberth HW, Koniger SJ, Rascher W, Kuhl PG, Schweer H. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol. 1987;1:491–7.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  • T. Harish Varma
    • 1
  • Ashish Sharma
    • 1
  • S. Santhiya
    • 1
  • Lesa Dawman
    • 1
  • Karalanglin Tiewsoh
    • 1
  1. 1.Department of PediatricsPost Graduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations